Home › Funds › Broadleaf Partners, LLC › JNJ

Broadleaf Partners, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Broadleaf Partners, LLC reported holding 7,326 shares of JNJ (JOHNSON & JOHNSON) in its Q2 2026 13F filing — a position valued at US$1.9M, representing 0.36% of its reported portfolio and ranking #42 among its reported holdings. Broadleaf Partners, LLC has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)7.33K sh
Reported value held$1.86M
Portfolio Weight0.36%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Broadleaf Partners, LLC's JNJ position evolved

Broadleaf Partners, LLC first disclosed a stake in JNJ in Q3 2023 at 7,223 shares (US$1.1M). The position peaked in Q1 2026 at 7,726 shares, worth US$1.9M. Across 12 filings, Broadleaf Partners, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 7,326 shares valued at US$1.9M — a reduction of -400 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 7.22K $1.12M New
Q4 2023 7.22K $1.13M Hold
Q1 2024 7.22K $1.14M Hold
Q2 2024 7.21K $1.05M Hold
Q3 2024 7.21K $1.17M Hold
Q4 2024 7.21K $1.04M Hold
Q1 2025 7.21K $1.20M Hold
Q2 2025 7.21K $1.10M Hold
Q3 2025 7.30K $1.35M Add
Q4 2025 7.35K $1.52M Add
Q1 2026 7.73K $1.89M Add
Q2 2026 7.33K $1.86M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Broadleaf Partners, LLC held JNJ?

Broadleaf Partners, LLC has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Broadleaf Partners, LLC's current position in JNJ?

As of Q2 2026, Broadleaf Partners, LLC holds 7.33K shares of JNJ (JOHNSON & JOHNSON), valued at $1.86M, representing 0.36% of its reported portfolio and ranking #42.

Has Broadleaf Partners, LLC been buying or selling JNJ?

In the latest 13F filing (Q2 2026), Broadleaf Partners, LLC reduced its position in JNJ. The position peaked in Q1 2026 at 7.73K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.